Simple and cheap CRISPR/Cas12a biosensor based on plug-and-play of DNA aptamers for the detection of endocrine-disrupting compounds

Talanta. 2023 Oct 1:263:124761. doi: 10.1016/j.talanta.2023.124761. Epub 2023 May 30.

Abstract

Endocrine-disrupting compounds (EDCs) are widely distributed in the environment. Here, we present a CRISPR/Cas12a (CAS) biosensor based on DNA aptamers for point-of-care detection of EDCs. Two typical EDCs, 17β-estradiol (E2) and bisphenol A (BPA), were selected to be detected by the CAS biosensors via the plug-and-play of their DNA aptamers. The results indicated that the performance of the CAS biosensors can be well regulated by controlling the trans-cleavage activity of Cas12a on a single-stranded DNA reporter and optimizing the sequence and ratio of DNA aptamer and activator DNA. Ultimately, two reliable and specific biosensors were developed, with the linear range and limit of detection of 0.2-25 nM and 0.08 nM for E2 and of 0.1-250 nM and 0.06 nM for BPA, respectively. Compared to the existing detection methods, the CAS biosensors showed higher reliability and sensitivity with simple operation, short detection time, and no costly equipment.

Keywords: 17β-estradiol; Bisphenol A; CRISPR/Cas12a biosensor; DNA aptamers; Endocrine-disrupting compounds.

MeSH terms

  • Aptamers, Nucleotide* / genetics
  • Biosensing Techniques* / methods
  • CRISPR-Cas Systems
  • Estradiol
  • Reproducibility of Results

Substances

  • Aptamers, Nucleotide
  • Estradiol